Stay updated with breaking news from Applied Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
First partnership in the new QIAseq Platform Partnership to increase compatibility of QIAGEN NGS kits with third-party digital data-sharing and analytics companies Bringing together QIAGEN's
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced a new partnership with QIAGEN N.V. (NYSE: QGEN) that will pair QIAseq reagent technology with
Certification of QuantiFERON-TB Gold Plus under more stringent EU regulation, classified under Class CCertification marks milestone in QIAGEN’s transition to full compliance with new EU regulations for IVD performance and safetyQIAGEN will ensure continuous supply of QuantiFERON-TB Gold PlusVENLO, The Netherlands--(...
Certification of QuantiFERON-TB Gold Plus under more stringent EU regulation, classified under Class C Certification marks milestone in QIAGEN's transition to full compliance with new EU regulations
Start of worldwide diagnostic use follows the launch of upgraded EZ2 Connect for research use in 2021, builds on the success of EZ1 Connect platform found in thousands of labs worldwide EZ2